Setting Expectations When Prescribing Medication for the Treatment of Patients With Obesity
The worldwide prevalence of obesity more than doubled between 1990 and 2022 (men, 4.8%-14.0%; women, 8.8%-18.5%), with similar trends observed for obesity-related diseases, including type 2 diabetes mellitus. Despite this increase in prevalence, many individuals with obesity remain untreated. There...
Saved in:
| Main Author: | Angela Fitch, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2542454825000323 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medical Treatment Under Community Compulsory Treatment Orders – Are Medications Prescribed Lawfully?
by: Susannah Houston, et al.
Published: (2025-06-01) -
Medical treatment of obesity: peculiarities of medical treatments, information, responsibility and relation to medical treatment of obesity of patients
by: O. V. Lerman, et al.
Published: (2019-08-01) -
Evaluation of prescribing practices and treatment failure for purulent skin and soft tissue infections in patients with obesity
by: Mackenzie L. Miller, et al.
Published: (2025-01-01) -
Prevalence, patterns, and predictors of prescribing medications for opioid use disorder (MOUD) in the Inpatient setting
by: Ashley Burke, et al.
Published: (2024-12-01) -
Prescribing Medications in Patients with Decompensated Liver Cirrhosis
by: Deepak N. Amarapurkar
Published: (2011-01-01)